Beatriz Pendleton
Neurology · Cypress, TXNPI 1568082618
Payments from drug & device makers
What this record shows
30 manufacturers reported payments, led by Boston Scientific at 52.3% of the total. Reporting peaked in 2024 at $6,432 and has fallen 87.4% since, to $807 in 2025.
Across 200 payments — averaging $47.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- AbbVie$513
- CSL Behring$390
- Genentech USA, Inc.$384
- AstraZeneca$366
- UCB, Inc.$353
- plus $3K from 24 others
What the payments were for
- Grants$5,00052%
- Food & beverage$4,56648%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 1 | $5,000 |
| AbbVie | 26 | $513 |
| CSL Behring | 17 | $390 |
| Genentech USA, Inc. | 20 | $384 |
| AstraZeneca(2 entities) | 19 | $366 |
| UCB, Inc. | 16 | $353 |
| Acadia Pharmaceuticals Inc | 9 | $350 |
| Amgen | 13 | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $192 |
| Merz Pharmaceuticals, LLC | 7 | $156 |
| Sanofi | 7 | $151 |
| Argenx US, Inc. | 6 | $144 |
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| Biogen | 7 | $132 |
| Globus Medical | 2 | $132 |
| Medtronic | 3 | $131 |
| MDD US Operations, LLC | 2 | $119 |
| Eisai Inc. | 5 | $108 |
| Amneal Pharmaceuticals LLC | 2 | $106 |
| Novartis | 5 | $101 |
| Pfizer | 4 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $68 |
| EMD Serono, Inc. | 3 | $56 |
| Tanabe Pharma America, Inc. | 3 | $45 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Neurelis, Inc. | 1 | $23 |
| Cala Health, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERCISE$5,000
How this compares
$9,566 in reported general payments places this provider in the 70th percentile of 1,246 neurology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 12 | $412 |
Paid to pharmacies, not to this prescriber.
Other neurology in Cypress
- Ann BassSan Antonio$1.7M
- William OndoHouston$1.4M
- Nirav PavasiaDallas$1.4M
- Mirla AvilaLubbock$1.3M
- Michael SoileauGeorgetown$1.2M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Benjamin GreenbergDallas$773K
- Annette OkaiPlano$730K
- Waleed El-FekyDallas$587K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.